Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures. Its CorPath system allows the physician to perform procedures with a control console located within an interventional cockpit; and CorPath GRX system enables the precise robotic-assisted control of guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit.
Read More…
Industry, Sector and Symbol
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+1-508-6533335
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees90
Next Earnings Date11/5/2019 (Estimated)
OptionableNot Optionable
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) Frequently Asked Questions
What is Corindus Vascular Robotics' stock symbol?
Corindus Vascular Robotics trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CVRS."
How were Corindus Vascular Robotics' earnings last quarter?
Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) issued its quarterly earnings data on Thursday, August, 8th. The medical equipment provider reported ($0.06) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.05) by $0.01. The medical equipment provider had revenue of $4.58 million for the quarter, compared to analysts' expectations of $4.10 million. View Corindus Vascular Robotics' Earnings History.
When is Corindus Vascular Robotics' next earnings date?
What price target have analysts set for CVRS?
1 Wall Street analysts have issued 1 year price targets for Corindus Vascular Robotics' shares. Their predictions range from $4.28 to $4.28. On average, they anticipate Corindus Vascular Robotics' stock price to reach $4.28 in the next twelve months. This suggests a possible upside of 0.5% from the stock's current price. View Analyst Price Targets for Corindus Vascular Robotics.
What is the consensus analysts' recommendation for Corindus Vascular Robotics?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Corindus Vascular Robotics in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Corindus Vascular Robotics.
Has Corindus Vascular Robotics been receiving favorable news coverage?
News coverage about CVRS stock has been trending somewhat positive this week, InfoTrie reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Corindus Vascular Robotics earned a daily sentiment score of 0.9 on InfoTrie's scale. They also assigned news coverage about the medical equipment provider a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Corindus Vascular Robotics.
Are investors shorting Corindus Vascular Robotics?
Corindus Vascular Robotics saw a decline in short interest in the month of August. As of August 31st, there was short interest totalling 9,785,500 shares, a decline of 45.5% from the July 31st total of 17,963,600 shares. Based on an average daily volume of 3,420,000 shares, the short-interest ratio is currently 2.9 days. Approximately 7.4% of the shares of the company are sold short. View Corindus Vascular Robotics' Current Options Chain.
Who are some of Corindus Vascular Robotics' key competitors?
Some companies that are related to Corindus Vascular Robotics include Consort Medical (CSRT), Ekf Diagnostics (EKF), Immunodiagnostic Systems (IDH), Theralase Technologies (TLT), Intelligent Ultrasound Group (MED), LiDCO Group (LID), Deltex Medical Group (DEMG), Zecotek Photonics (ZMS), InspireMD (NSPR), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS).
What other stocks do shareholders of Corindus Vascular Robotics own?
Who are Corindus Vascular Robotics' key executives?
Corindus Vascular Robotics' management team includes the folowing people:
- Mr. Mark J. Toland, CEO, Pres & Director (Age 49)
- Mr. David W. Long, CFO, Sr. VP, Sec. & Treasurer (Age 49)
- Mr. Douglas Teany, Chief Operating Officer (Age 47)
- Ms. Nora Dutta, Sr. VP of HR
- Dr. J. Aaron Grantham, Chief Medical Officer of Cardiovascular
Who are Corindus Vascular Robotics' major shareholders?
Corindus Vascular Robotics' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.02%), Vanguard Group Inc. (2.56%), Nomura Holdings Inc. (0.50%), Nomura Holdings Inc. (0.50%), Bank of America Corp DE (0.50%) and JPMorgan Chase & Co. (0.38%). Company insiders that own Corindus Vascular Robotics stock include Hudson Executive Capital Lp, Louis A Cannon and Philips Nv Koninklijke. View Institutional Ownership Trends for Corindus Vascular Robotics.
Which major investors are selling Corindus Vascular Robotics stock?
CVRS stock was sold by a variety of institutional investors in the last quarter, including Susquehanna International Group LLP, Nomura Holdings Inc., Nomura Holdings Inc., US Bancorp DE, Commonwealth Equity Services LLC, Bronfman E.L. Rothschild L.P., Bank of America Corp DE and Morgan Stanley. View Insider Buying and Selling for Corindus Vascular Robotics.
Which major investors are buying Corindus Vascular Robotics stock?
CVRS stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Vanguard Group Inc., JPMorgan Chase & Co., Jane Street Group LLC, Bank of New York Mellon Corp, Charles Schwab Investment Management Inc., A.R.T. Advisors LLC and Renaissance Technologies LLC. Company insiders that have bought Corindus Vascular Robotics stock in the last two years include Hudson Executive Capital Lp and Louis A Cannon. View Insider Buying and Selling for Corindus Vascular Robotics.
How do I buy shares of Corindus Vascular Robotics?
Shares of CVRS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Corindus Vascular Robotics' stock price today?
One share of CVRS stock can currently be purchased for approximately $4.26.
How big of a company is Corindus Vascular Robotics?
What is Corindus Vascular Robotics' official website?
How can I contact Corindus Vascular Robotics?
Corindus Vascular Robotics' mailing address is 309 Waverley Oaks Rd Ste 105, WALTHAM, MA 02452-8451, United States. The medical equipment provider can be reached via phone at +1-508-6533335.
MarketBeat Community Rating for Corindus Vascular Robotics (NYSEAMERICAN CVRS)
MarketBeat's community ratings are surveys of what our community members think about Corindus Vascular Robotics and other stocks. Vote "Outperform" if you believe CVRS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVRS will underperform the S&P 500 over the long term. You may vote once every thirty days.
